Fed. Circ. Backs Gilead's Hep C Patent Win Against Idenix
A Federal Circuit panel on Wednesday affirmed a Patent Trial and Appeal Board ruling that Gilead Pharmasset LLC invented a hepatitis C treatment before Idenix Pharmaceuticals LLC and will be granted...To view the full article, register now.
Already a subscriber? Click here to view full article